Source:http://linkedlifedata.com/resource/pubmed/id/16855387
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
13
|
pubmed:dateCreated |
2006-7-24
|
pubmed:abstractText |
The INK4/ARF locus encodes three tumor suppressors, p15(INK4b), p16(INK4a) and ARF, which together constitute one of the main anti-oncogenic defenses of mammalian organisms. The activity of these tumor suppressors depends mostly on the transcriptional status of the locus. Recently, we have identified a conserved DNA element with the capacity to regulate the locus in a global manner. Inactivation of this element, which we have named RD(INK4/ARF), results in the silencing of the entire INK4/ARF locus. Interestingly, RD(INK4/ARF) is both a transcriptional regulatory element and a replication origin. The replication protein Cdc6 binds to RD(INK4/ARF) and is able to recruit histone deacetylases that, in turn, result in the heterochromatinization and repression of the INK4/ARF locus. This model has striking parallelisms with the silencing of the yeast mating-type loci, and it is a novel oncogenic mechanism that connects the replication machinery with the inactivation of tumor suppressors.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
1551-4005
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
5
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1382-4
|
pubmed:meshHeading |
pubmed-meshheading:16855387-Animals,
pubmed-meshheading:16855387-Cyclin-Dependent Kinase Inhibitor p16,
pubmed-meshheading:16855387-Humans,
pubmed-meshheading:16855387-Models, Biological,
pubmed-meshheading:16855387-Protein Binding,
pubmed-meshheading:16855387-Signal Transduction,
pubmed-meshheading:16855387-Tumor Suppressor Protein p14ARF
|
pubmed:year |
2006
|
pubmed:articleTitle |
A new mechanism of inactivation of the INK4/ARF locus.
|
pubmed:affiliation |
Tumor Suppression Group, Spanish National Cancer Center (CNIO), Madrid, Spain.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|